In the 18 years between 1970 and 1987, 504 patients were found to have hepatitis B surface antigen (HBsAg) in their blood. Acute hepatitis was present in 184 patients and six died (3 3 %). The annual incidence of acute hepatitis B virus infection in Northern Ireland was about one -quarter that of England and Wales. A decrease in acute infection occurred in 1986-87, while in England and Wales acute infection has fallen by more than half since the peak in 1984. Hepatitis B virus infection in health care staff and patients in high risk groups were reviewed: 32 % were in those offoreign origin or who had known foreign contacts. In blood donors there was a marked fall in incidence of hepatitis B surface antigen carriage from 1982 onwards: the incidence in antenatal patients and those screened for rubella antibody (mainly females) was half that of new blood donors in 1972-81. Carrier rates in blood donors and antenatal patients were less than those from other parts of the United Kingdom. All indices show that Northern Ireland has a lower incidence of hepatitis B virus infection than the rest of the United Kingdom.
INTRODUCTION
Hepatitis B virus infection is a large problem in the world. It has been estimated that there are in excess of 200 million human carriers, but the distribution of these carriers is uneven. The prevalence of carriers in northern Europe, North America and Australia is 0 -1 % or less, but rises to 20% or more in some parts of Africa, Asia and in the Pacific region. Hepatitis B vaccine is now available but it is expensive. A knowledge of local epidemiology is important to assess whether vaccine is required. The categories of patients who were HBsAg -positive and the number of patients who had acute hepatitis B virus infections are shown in Table 1 . There were 184 patients with symptoms or signs of acute hepatitis, accounting for 65% of the total diagnosed by the Regional Virus Laboratory (131 males and 53 females). The average annual incidence of acute infection per 100,000 population was 0 95 for males and 0 37 for females. There were six deaths, a mortality rate of 3 3%. In the age group 15 -64 years there were 1 25 males and 50 females, an average annual incidence per 100,000 population of 148 for males and 0-58 for females. Three hundred and twenty patients were carriers in high risk groups or were detected on screening. The case of a hospital cleaner who developed hepatitis after a needlestick injury emphasises that resheathing needles safely should prevent such injuries in people 'downstream' in the disposal chain from those who used the needles. The risk of acquiring hepatitis B virus infection following an accidental needlestick injury from a carrier ranges from 6 % to 30 %, which is far in excess of the risk of human immunodeficiency virus infection following a similar injury with an infected patient where the risk is <1 %.4 Four laboratory staff became infected with hepatitis B virus. Statistics from England indicate that the annual rate in laboratory staff doubled from 18 to 37/100,000 between 1975-79 and 1980-84,2 while in Northern Ireland three of the four cases occurred between 1971 and 1974. Nevertheless the overall incidence for Northern Ireland is similar to that of England in 1980 -84. Transmission of hepatitis B virus by blood and blood products such as cryoprecipitate and factor VIII has almost ceased following the screening of blood donors and the development of more sensitive and specific tests. There was no evidence that haemophilia patients became infected after 1982 and patients who received multiple transfusions after 1980 did not have acute hepatitis B virus infections. Tattooing is a high risk procedure, particularly if carried out abroad in a country where the incidence of hepatitis B virus infection is increased. Any procedure which uses unsterilised instruments such as ear -piercing, acupuncture, electrolysis, unregistered chiropody and accidental skin piercing in hairdressing and barbers carries a risk. The association of infection with previous surgical procedures is difficult to prove. There was probably only a chance association in those patients who gave a history of dental treatment in the previous six months, since dental treatment is common and there was no obvious 'clustering' of patients. There were three 'clusters' of cases identified involving a total of 13 patients. Advice was given to the staff involved, measures to preserve asepsis were instituted, and no further cases were indentified. It has been estimated that in England and Wales the average annual risk of a patient developing acute hepatitis B virus infection as part of a cluster caused by staff during surgical procedures was one in a million operations. '4 A fall in number of positive HBsAg tests did not occur during 1982 -87 in the antenatal patients or in the predominantly female patients screened for rubella antibody. This again suggests that the fall observed in the blood donors during this period was due to self-exclusion of male donors. The Northern Ireland incidence of positive tests in the antenatal patients and the patients screened for rubella antibody was less than half that found in new donors during 1972-81 and again confirms the two-threefold lower incidence of hepatitis B virus infection in females. The incidence is five times lower than that detected in Oxfordshire and Northamptonshire,'5 eight times lower than in the West Midlands,16 and 20 times lower than in London. '3 In the indigenous Northern Ireland population the incidence is still lower. The use of vaccine should be based on local epidemiology. The small groups who really are at increased risk might be offered vaccine, rather than the blanket coverage at present recommended. This strategy is logical and cheaper, but it is more important that safe working practices should be taught since good technique protects against all microbiological hazards.17
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